1. Brain drug targeting; the future of brain drug development;Pardridge,2001
2. Characterization of the relaxant effects of vasoactive intestinal peptide (VIP) and PHI on isolated brain arteries;Suzuki;Brain Res.,1984
3. Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide;McCulloch;Am. J. Physiol.,1980
4. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood–brain barrier drug delivery system;Wu;J. Pharmacol. Exp. Ther.,1996
5. Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity;Sakane;Pharm. Res.,1997